The Impress of Low Level lasers in the Treatment of Patients with in Virus COVID-19 (SARS-CoV-2)

α
ehsan_kamani
ehsan_kamani
σ
Ehsan Kamani
Ehsan Kamani
α Arak University of Medical Sciences Arak University of Medical Sciences

Send Message

To: Author

The Impress of Low Level lasers in the Treatment of Patients with in Virus COVID-19 (SARS-CoV-2)

Article Fingerprint

ReserarchID

35804

The Impress of Low Level lasers in the Treatment of Patients with in Virus COVID-19 (SARS-CoV-2) Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Abstract

Introduction-Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei Province, Central China. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At present, the newly identified SARS-CoV-2 has caused a large number of deaths with Millions person of confirmed cases worldwide, posing a serious threat to public health. However, there are no clinically approved vaccines or specific therapeutic drugs available for COVID-19(1). The evidence shows that blue 450 nm light is antimicrobial against numerous bacteria, and that it accounts for Niels Ryberg Finsen’s Nobelwinning treatment of tuberculosis. Further evidence shows that blue light inactivates several viruses, including the common flu coronavirus, and that in experimental animals, red and near infrared light reduce respiratory disorders, similar to those complications associated with coronavirus infection. Moreover, in patients, red light has been shown to alleviate chronic obstructive lung disease and bronchial asthma(2). LLLT can be added to the conventional treatment in COVID-19 at different stages of the disease.

References

7 Cites in Article
  1. Heng Li,Shang-Ming Liu,Xiao-Hua Yu,Shi-Lin Tang,Chao-Ke Tang (2020). Coronavirus disease 2019 (COVID-19): current status and future perspectives.
  2. C Enwemekaa,V Bumahab,D Masson-Meyersc (2020). Light as a potential treatment for pandemic coronavirus infections: a perspective.
  3. Soheila Mokmeli,Mariana Vetrici (2020). Low level laser therapy as a modality to attenuate cytokine storm at multiple levels, enhance recovery, and reduce the use of ventilators in COVID-19.
  4. E Kamani,M Razaghi (2020). Application of Laser Blue Light With a Wavelength of 405 nm in the Treatment of Patients with the Virus COVID-19.
  5. M Razzaghi,E Kamani (2020). Role low-power blue laser with a wavelength of 405 nm in increasing the level of nitric oxide in increasing the resistance of cells to the virus (COVID-19) and its effect on virus (COVID-19) mortality in vitro.
  6. E Kamani (2020). AN OVERVIEW OF CORONA VIRUS DISEASE OF 2019 (COVID-19).
  7. Sirous Momenzadeh,Vahid Akhyani,Zahra Razaghi,Asghar Ebadifar,Mohammadzaki Abbasi (2015). Evaluation of the Effects of Intravenous and Percutaneous Low Level Laser Therapy in the Management of Shoulder Myofascial Pain Syndrome.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

ehsan_kamani. 2021. \u201cThe Impress of Low Level lasers in the Treatment of Patients with in Virus COVID-19 (SARS-CoV-2)\u201d. Global Journal of Medical Research - F: Diseases GJMR-F Volume 21 (GJMR Volume 21 Issue F2): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-F Classification: NLMC Code: WO 511
Version of record

v1.2

Issue date

April 22, 2021

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 2098
Total Downloads: 935
2026 Trends
Related Research

Published Article

Introduction-Coronavirus disease 2019 (COVID-19) originated in the city of Wuhan, Hubei Province, Central China. COVID-19 is caused by a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At present, the newly identified SARS-CoV-2 has caused a large number of deaths with Millions person of confirmed cases worldwide, posing a serious threat to public health. However, there are no clinically approved vaccines or specific therapeutic drugs available for COVID-19(1). The evidence shows that blue 450 nm light is antimicrobial against numerous bacteria, and that it accounts for Niels Ryberg Finsen’s Nobelwinning treatment of tuberculosis. Further evidence shows that blue light inactivates several viruses, including the common flu coronavirus, and that in experimental animals, red and near infrared light reduce respiratory disorders, similar to those complications associated with coronavirus infection. Moreover, in patients, red light has been shown to alleviate chronic obstructive lung disease and bronchial asthma(2). LLLT can be added to the conventional treatment in COVID-19 at different stages of the disease.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

The Impress of Low Level lasers in the Treatment of Patients with in Virus COVID-19 (SARS-CoV-2)

Ehsan Kamani
Ehsan Kamani

Research Journals